GoAI
Get started
Wai Yuen Tong Medicine Holdings Limited logo

Wai Yuen Tong Medicine Holdings Limited

0897.HK

HKSEHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

HK$0.29

HK$0.00 · 0.00%

Aug 21, 4:08 PM HKTData delayed

0897.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Wai Yuen Tong Medicine Holdings Limited operates as an investment holding company with a multifaceted business portfolio. Its core activities encompass the production, processing, and retail distribution of traditional Chinese medicines, Western pharmaceuticals, and a range of health and personal care products. These offerings reach customers across Hong Kong, mainland China, Macau, and international markets. The company's Chinese medicine and health food lines are marketed under the Wai Yuen Tong brand, while its Western pharmaceutical and personal care items are available under the Madame Pearl's and Pearl's labels. Beyond its product-focused segments, the group also engages in property investment, ownership, and sales, provides financial services, and oversees an agricultural produce exchange. As of March 31, 2022, Wai Yuen Tong maintained 63 retail stores in Hong Kong. Founded in 1897, the company is headquartered in Kowloon Bay, Hong Kong, and operates as a subsidiary of Rich Time Strategy Limited.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
HK
CEO
Kit Man Chan
Listed since
Oct 31, 1997
Employees
691

Market position

52-week range

Current HK$0.29

Open
HK$0.29
Previous close
HK$0.29
Volume
960
0.01× average
Average volume
91.05K
Average daily volume
Market cap
323.17M HKD
Beta
-0.07
Market reference 1
50-day average
HK$0.3033
-4.39% below average
200-day average
HK$0.348
-16.67% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
517.23M HKD
P/E (TTM)
80.56×
P/B (TTM)
0.27×
P/S (TTM)
0.47×
EV / EBITDA
7.71×
Earnings yield
1.08%
Free cash flow yield
15.34%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
52.96%
Operating margin
-2.36%
Net margin
0.58%
Return on equity
0.34%
Return on assets
0.25%
Return on invested capital
-1.16%

Financial health

Debt / equity
0.24×
Current ratio
1.4×
Altman Z-score
1.3
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends59%35%10%-14%Gross margin, FY2021: 41.26%Gross margin, FY2022: 47.38%Gross margin, FY2023: 50.37%Gross margin, FY2024: 50.51%Gross margin, FY2025: 52.96%Operating margin, FY2021: 4.04%Operating margin, FY2022: 4.01%Operating margin, FY2023: 5.22%Operating margin, FY2024: -4.25%Operating margin, FY2025: -2.50%Net margin, FY2021: -7.83%Net margin, FY2022: -1.59%Net margin, FY2023: -1.96%Net margin, FY2024: 0.95%Net margin, FY2025: 0.58%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 41.26%. Gross margin FY2022 47.38%. Gross margin FY2023 50.37%. Gross margin FY2024 50.51%. Gross margin FY2025 52.96%. Operating margin FY2021 4.04%. Operating margin FY2022 4.01%. Operating margin FY2023 5.22%. Operating margin FY2024 -4.25%. Operating margin FY2025 -2.50%. Net margin FY2021 -7.83%. Net margin FY2022 -1.59%. Net margin FY2023 -1.96%. Net margin FY2024 0.95%. Net margin FY2025 0.58%.

Income trends

Revenue

683.44M HKD-8.30%

Operating income

−17.1M HKD+46.05%

Net income

3.99M HKD-43.77%
Income trends across reported periods1.54B HKD941.31M HKD341.18M HKD−258.94M HKDRevenue, FY2021: 1.39B HKDRevenue, FY2022: 1.29B HKDRevenue, FY2023: 783.88M HKDRevenue, FY2024: 745.3M HKDRevenue, FY2025: 683.44M HKDOperating income, FY2021: 56.16M HKDOperating income, FY2022: 51.55M HKDOperating income, FY2023: 40.88M HKDOperating income, FY2024: −31.7M HKDOperating income, FY2025: −17.1M HKDNet income, FY2021: −108.91M HKDNet income, FY2022: −20.52M HKDNet income, FY2023: −15.36M HKDNet income, FY2024: 7.1M HKDNet income, FY2025: 3.99M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.39B HKD. Revenue FY2022 1.29B HKD. Revenue FY2023 783.88M HKD. Revenue FY2024 745.3M HKD. Revenue FY2025 683.44M HKD. Operating income FY2021 56.16M HKD. Operating income FY2022 51.55M HKD. Operating income FY2023 40.88M HKD. Operating income FY2024 −31.7M HKD. Operating income FY2025 −17.1M HKD. Net income FY2021 −108.91M HKD. Net income FY2022 −20.52M HKD. Net income FY2023 −15.36M HKD. Net income FY2024 7.1M HKD. Net income FY2025 3.99M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue683.44M HKD745.3M HKD783.88M HKD1.29B HKD1.39B HKD
Cost of goods sold321.51M HKD368.85M HKD389.07M HKD676.89M HKD817.26M HKD
Gross profit361.93M HKD376.45M HKD394.81M HKD609.54M HKD574.15M HKD
Research and development1.86M HKD1.12M HKD1.79M HKD1.9M HKD1.3M HKD
Selling, general, and administrative377.17M HKD408.3M HKD353.93M HKD316.29M HKD499.2M HKD
Operating expenses379.03M HKD408.15M HKD355.72M HKD557.99M HKD517.99M HKD
Interest income39.9M HKD45.85M HKD45.79M HKD44.64M HKD15.93M HKD
Interest expense17.59M HKD28.16M HKD40.79M HKD29.51M HKD95.7M HKD
Depreciation and amortization84.15M HKD90.48M HKD89.17M HKD95.23M HKD107.8M HKD
Operating income−17.1M HKD−31.7M HKD40.88M HKD51.55M HKD56.16M HKD
Net income3.99M HKD7.1M HKD−15.36M HKD−20.52M HKD−108.91M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
0.02

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.07-0.01-0.08-0.16Q1 '21Q3 '21Q1 '22Q4 '22Q2 '23Q1 '24Q2 '24Q4 '24
Q1 2021, reported Mar 31, 2021: actual -0.116, estimate —, surprise —, Comparison unavailable. Q3 2021, reported Sep 30, 2021: actual 0.011, estimate —, surprise —, Comparison unavailable. Q1 2022, reported Mar 31, 2022: actual -0.1, estimate —, surprise —, Comparison unavailable. Q4 2022, reported Nov 26, 2022: actual -0.043, estimate —, surprise —, Comparison unavailable. Q2 2023, reported Jun 29, 2023: actual 0.027, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 7, 2024: actual 0.003, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 27, 2024: actual -0.016, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 27, 2024: actual 0.021, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates785.75M553.6M321.46M89.32MQ1 '21Q3 '21Q1 '22Q4 '22Q2 '23Q1 '24Q2 '24Q4 '24
Q1 2021, reported Mar 31, 2021: actual 599.02M HKD, estimate —, surprise —, Comparison unavailable. Q3 2021, reported Sep 30, 2021: actual 656.08M HKD, estimate —, surprise —, Comparison unavailable. Q1 2022, reported Mar 31, 2022: actual 735.33M HKD, estimate —, surprise —, Comparison unavailable. Q4 2022, reported Nov 26, 2022: actual 606.13M HKD, estimate —, surprise —, Comparison unavailable. Q2 2023, reported Jun 29, 2023: actual 680.3M HKD, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 7, 2024: actual 678.8M HKD, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 27, 2024: actual 105.08M HKD, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 27, 2024: actual 346.84M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.177

2024 complete year+248.5% since 2011

Corporate action history

Dividend

Ex-dividend Aug 22, 2024

HK$0.177

Special

Record Aug 23, 2024 · Payment Sep 6, 2024

Dividend

Ex-dividend Jul 21, 2014

HK$0.0025

Annual

Dividend

Ex-dividend Aug 27, 2013

HK$0.0025

Annual

Dividend

Ex-dividend Aug 3, 2011

HK$0.0025

Annual

Continue in GoAI

Research 0897.HK

research.disclaimer